Sales and Marketing
NICE declines to recommend Astellas’ Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia
January 23, 2020 Sales and Marketing Astellas, NHS, NICE, UK, Xospata, acute myeloid leukaemia
No NICE recommendation for AstraZeneca’s Tagrisso in EGFR+ lung cancer
January 22, 2020 Research and Development, Sales and Marketing AstraZeneca, NICE, Tagrisso, pharma
EU approval for Roche’s Polivy combo in relapsed/refractory B-cell lymphoma
January 21, 2020 Manufacturing and Production, Sales and Marketing Cancer, Polivy, Roche, lymphoma, pharma
Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea
January 21, 2020 Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma
FDA warning letters to Indian pharmaceutical companies double in 2019
January 20, 2020 Sales and Marketing Indian Pharma, Indian Pharmaceuticals
Lynparza secures accelerated FDA review for metastatic castration-resistant prostate cancer
January 20, 2020 Sales and Marketing Cancer, FDA, lynparza, pharma
Collaborating to realise the potential of precision medicine
January 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma
US judge slashes Johnson & Johnson damages in Risperdal case
January 20, 2020 Sales and Marketing Big Pharma, Johnson & Johnson, Johnson & Johnson talc powder
NICE turns down Bayer’s tumour-agnostic therapy Vitrakvi over evidence concerns
January 20, 2020 Sales and Marketing Bayer, Cancer, NICE, Vitravki
WHO officials say Wuhan viral pneumonia outbreak can be passed from person to person
January 20, 2020 Sales and Marketing China, Sars, Viral pneumonia, WHO, World Health Organisation, Wuhan Outbreak
Ipsen appoints new Exec VP and Chief Medical Officer
January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Top Ten most popular articles on Pharmafile.com this week
January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva
Japan welcomes approval of ViiV’s Dovato for HIV-1
January 17, 2020 Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma
Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD
January 17, 2020 Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma
Lynparza tablets approved for NHS use in platinum-sensitive, BRCA-mutated ovarian, fallopian tube or peritoneal cancer
January 16, 2020 Sales and Marketing AstraZeneca, MSD, NHS, NICE, UK, lynparza
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
